Literature DB >> 7558126

Immunoregulatory activities of eicosanoids in the rainbow trout (Oncorhynchus mykiss).

J Knight1, A F Rowley.   

Abstract

Eicosanoids such as prostaglandins (PG), leukotrienes (LT) and lipoxins (LX) have been shown to be potent immunoregulatory molecules in mammals. To determine if they have similar roles in 'lower' animals, rainbow trout (Oncorhynchus mykiss) were immunized with either sheep erythrocytes or Aeromonas salmonicida in the presence or absence of the stable analogue of PGE2, 16,16-dimethyl-PGE2, and the number of plaque-forming cells (PFC) or specific antibody levels determined. The higher dose of 16,16-dimethyl-PGE2 (200 micrograms/kg body weight) caused a significant reduction in both PFC number and antibody titre compared with the control. The effect of PGE2, PGE3, 16,16-dimethyl-PGE2, LTB4, LTB5, LXA4, 12-HETE and 12-HEPE on PFC generation following the in vitro challenge of trout splenocytes with sheep erythrocytes was also determined. All of the prostaglandins tested showed a dose-dependent inhibition of PFC after 11 days in culture, while of the remaining eicosanoids only LXA4 had any effect on PFC number, with a dose-dependent stimulatory effect. The cyclo-oxygenase inhibitor, indomethacin, also caused a stimulation in the number of PFC generated, with a maximal effect at c. 25 microM, while the lipooxygenase inhibitors, esculetin and nordihydroguaiaretic acid (5-100 microM), had no significant effect on PFC generation at all concentrations tested. The present results show that, as in mammals, prostaglandins and the cyclo-oxygenase pathway are also important in the regulation of the piscine humoral immune response. Of the lipoxygenase products tested, however, only LXA4 had any significant effect on PFC generation, suggesting that these compounds have only a limited role to play in immune regulation in this organism. Overall this work shows that eicosanoids have a long evolutionary history in immunoregulation, probably dating back at least to the appearance of bony fish some 400 million years ago.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558126      PMCID: PMC1383911     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets.

Authors:  N Gualde; D Atluru; J S Goodwin
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

3.  Expression of IgG memory response in vitro to thymus-dependent and thymus-independent antigens.

Authors:  T V Tittle; M B Rittenberg
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

4.  Effects of prostaglandin E2 and preincubation on lectin-stimulated proliferation of human T cell subsets.

Authors:  N Gualde; J S Goodwin
Journal:  Cell Immunol       Date:  1982-07-01       Impact factor: 4.868

5.  Inhibition of human B cell responsiveness by prostaglandin E2.

Authors:  N J Simkin; D F Jelinek; P E Lipsky
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

6.  Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.

Authors:  N R Ferreri; W C Howland; H L Spiegelberg
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

7.  The effect of eicosanoids on rainbow trout, Oncorhynchus mykiss, leucocyte proliferation.

Authors:  C J Secombes; K Clements; I Ashton; A F Rowley
Journal:  Vet Immunol Immunopathol       Date:  1994-09       Impact factor: 2.046

8.  Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding.

Authors:  U Ramstedt; J Ng; H Wigzell; C N Serhan; B Samuelsson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites.

Authors:  A A Aderem; D S Cohen; S D Wright; Z A Cohn
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  5 in total

1.  Fish macrophages express a cyclo-oxygenase-2 homologue after activation.

Authors:  J Zou; N F Neumann; J W Holland; M Belosevic; C Cunningham; C J Secombes; A F Rowley
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Modification of membrane fatty acid composition, eicosanoid production, and phospholipase A activity in Atlantic salmon (Salmo salar) gill and kidney by dietary lipid.

Authors:  J G Bell; B M Farndale; J R Dick; J R Sargent
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

3.  Relative quantification of immune-regulatory genes in two rainbow trout strains, Oncorhynchus mykiss, after exposure to Myxobolus cerebralis, the causative agent of whirling disease.

Authors:  Vanessa I C Severin; Mansour El-Matbouli
Journal:  Parasitol Res       Date:  2007-05-27       Impact factor: 2.289

4.  Role of pathogen-derived cell wall carbohydrates and prostaglandin E2 in immune response and suppression of fish immunity by the oomycete Saprolegnia parasitica.

Authors:  Rodrigo Belmonte; Tiehui Wang; Gary J Duncan; Ida Skaar; Hugo Mélida; Vincent Bulone; Pieter van West; Christopher J Secombes
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

5.  Altered gene expression patterns of innate and adaptive immunity pathways in transgenic rainbow trout harboring Cecropin P1 transgene.

Authors:  Jay H Lo; Chun-Mean Lin; Maria J Chen; Thomas T Chen
Journal:  BMC Genomics       Date:  2014-10-11       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.